HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beta adrenergic agonists.

Abstract
Beta adrenergic agonists are the most widely used agents in the management of bronchospasm as a result of their rapid onset of action and predictable efficacy. Administration of these agents by inhalation provides several advantages, including rapid effect, decreased adverse effects, and fewer drug interactions. The newer agents have greater beta-2 selectivity, which contributes to improved tolerance of these agents. Tremor is usually the dose-limiting side effect for the beta-2 selective agents. Other adverse effects include tachycardia, increased blood pressure, headache, anxiety, abnormal glucose metabolism, and hypokalemia. Controversy surrounding the use of beta adrenergic agonists includes reports of an increased mortality rate with increased use of these agents. Current information is inconclusive and should not limit the use of these agents in the management of acute bronchospasm. The significance of tolerance with prolonged administration is also an unresolved issue.
AuthorsL P Sterling
JournalAACN clinical issues (AACN Clin Issues) Vol. 6 Issue 2 Pg. 271-8 (May 1995) ISSN: 1079-0713 [Print] United States
PMID7743429 (Publication Type: Journal Article, Review)
Chemical References
  • Adrenergic beta-Agonists
Topics
  • Acute Disease
  • Adrenergic beta-Agonists (pharmacology, therapeutic use)
  • Adult
  • Bronchial Spasm (drug therapy)
  • Child
  • Dose-Response Relationship, Drug
  • Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: